Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab plus chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer

Aparicio, T; Bouche, O; Francois, E; Retornaz, F; Barbier, E; Taieb, J; Kirscher, S; Etienne, PL; Faroux, R; Akouz, FK; El Hajbi, F; Locher, C; Rinaldi, Y; Lecomte, T; Lavau-Denes, S; Baconnier, M; Oden-Gangloff, A; Genet, D; Bedenne, L; Paillaud, E

Aparicio, T (reprint author), CHU St Louis, AP HP, Dept Gastroenterol, Paris, France.; Aparicio, T (reprint author), Univ Paris 07, Sorbonne Paris Cite, Paris, France.; Aparicio, T (reprint author), Univ Paris 07, St Louis Hosp, AP HP, Gastroenterol Dept,

EUROPEAN JOURNAL OF CANCER, 2018; 97 (): 16

Abstract

Background: Older patients have frailty characteristics that impair the transposition of treatment results found in younger patients. Predictive facto......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索